Many minds, better together.
Ardena was formed in 2017, following the merging of three companies with complementary capabilities: Pharmavize in Belgium, and Crystallics and Analytical Biochemical Laboratory (ABL) in the Netherlands.
The companies came together to provide customers with an integrated service throughout drug development, helping pharmaceutical companies to reach important clinical milestones by working with one expert partner.
Our combined offering as Ardena gives drug development companies access to a range of specialist services, including solid-state chemistry, formulation & (bio)analytical development and GMP clinical supply manufacturing.
Our headquarters in Ghent, the former Pharmavize facility, has been in the pharmaceutical business for over 20 years, providing CMC drug and dossier development services. Our site in Amsterdam, the former Crystallics site, has been delivering solid state research expertise to customers for over a decade. While our GLP-compliant site in Assen, the former ABL site, has extensive experience in developing, validating and applying bioanalytical methods including LC-MS/MS and immunochemistry.
In 2018 we bought ChemConnection to add nanomedicine expertise to our offering and to expand our capabilities in drug substance manufacture and analysis. ChemConnection’s established research and production site in Oss, the Netherlands, is home to more than 60 scientists with expertise in process development, analytical R&D, GMP production and QA of drug substances.
Together as Ardena, our team collectively guides customers into making smarter formulation choices, reducing the risk of clinical failure and speeding up time to trials.